Literature DB >> 9498057

Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6).

H Sasaki1, H Kojima, I Yabe, K Tashiro, T Hamada, H Sawa, H Hiraga, K Nagashima.   

Abstract

SCA6 is an autosomal dominant spinocerebellar ataxia (SCA) caused by a small CAG repeat expansion of the gene encoding an alpha-1A-voltage-dependent Ca channel gene subunit on chromosome 19p13. A Japanese woman with SCA6, with a 7-year history of progressive pure cerebellar ataxia, died of malignant lymphoma. Systematic neuropathological examination showed that neuronal degeneration was confined to the cerebellar Purkinje cells and, to a lesser degree, the granular cells, without any involvement of other central nervous system structures. Such pathological selectivity correlates with the localized expression of the responsible gene, and coincides with the neurological manifestation. These findings might contribute to establishing the phenotype of the SCA6 via comparison with other dominant ataxias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498057     DOI: 10.1007/s004010050787

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Spinocerebellar ataxia type 6 with motor neuron loss: a follow-up autopsy report.

Authors:  Shinji Ohara; Teruaki Iwahashi; Takashi Oide; Ryoichi Hayashi; Takashi Nakajima; Kinya Ishikawa; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

2.  Modulation of error-sensitivity during a prism adaptation task in people with cerebellar degeneration.

Authors:  Ritsuko Hanajima; Reza Shadmehr; Shinya Ohminami; Ryosuke Tsutsumi; Yuichiro Shirota; Takahiro Shimizu; Nobuyuki Tanaka; Yasuo Terao; Shoji Tsuji; Yoshikazu Ugawa; Motoaki Uchimura; Masato Inoue; Shigeru Kitazawa
Journal:  J Neurophysiol       Date:  2015-08-26       Impact factor: 2.714

3.  Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.

Authors:  Maria R Stefanescu; Moritz Dohnalek; Stefan Maderwald; Markus Thürling; Martina Minnerop; Andreas Beck; Marc Schlamann; Joern Diedrichsen; Mark E Ladd; Dagmar Timmann
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

Review 4.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

5.  Cognitive and social cognitive functioning in spinocerebellar ataxia : a preliminary characterization.

Authors:  P Garrard; N H Martin; P Giunti; L Cipolotti
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

6.  Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis.

Authors:  O Y Bang; P H Lee; S Y Kim; H J Kim; K Huh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

7.  Cerebellar contributions to adaptive control of saccades in humans.

Authors:  Minnan Xu-Wilson; Haiyin Chen-Harris; David S Zee; Reza Shadmehr
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

8.  Macro- and microstructural changes in patients with spinocerebellar ataxia type 6: assessment of phylogenetic subdivisions of the cerebellum and the brain stem.

Authors:  K Sato; K Ishigame; S H Ying; K Oishi; M I Miller; S Mori
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-28       Impact factor: 3.825

Review 9.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

10.  The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.

Authors:  Taro Ishiguro; Kinya Ishikawa; Makoto Takahashi; Masato Obayashi; Takeshi Amino; Nozomu Sato; Masaki Sakamoto; Hiroto Fujigasaki; Fuminori Tsuruta; Ricardo Dolmetsch; Takao Arai; Hidenao Sasaki; Kazuro Nagashima; Takeo Kato; Mitsunori Yamada; Hitoshi Takahashi; Yoshio Hashizume; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2009-12-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.